Target Name: EPHA6
NCBI ID: G285220
Review Report on EPHA6 Target / Biomarker Content of Review Report on EPHA6 Target / Biomarker
EPHA6
Other Name(s): OTTHUMP00000217916 | OTTHUMP00000217552 | EPHA6 variant 1 | ephrin receptor EphA6 | DKFZp434C1418 | EPH homology kinase 2 | EPH-like kinase 12 | EPH receptor A6, transcript variant 1 | Ephrin type-A receptor 6 | EPHA6_HUMAN | EPH receptor A6 | FLJ35246 | EHK2 | OTTHUMP00000217917 | EHK-2 | Ephrin receptor EphA6 | EK12 | PRO57066 | EPA6 | HEK12 | Ephrin type-A receptor 6 (isoform a)

EPHA6: Key Enzyme in TOR and PI3K/Akt Signaling Pathways

EPHA6 (E)-phenyl-L-alanine aminotransferase 6 is a protein that is expressed in various tissues and organs in the body. It is a key enzyme in the metabolism of phenylalanine, which is a protein that is synthesized from the amino acid lysine.

EPHA6 is a member of the superfamily of proteins that are known as alkaline phosphatases, and it is involved in the regulation of various cellular processes. In particular, it is involved in the regulation of cell signaling pathways, and it is a key enzyme in the signaling pathway known as the TOR pathway.

The TOR pathway is a well-known signaling pathway that is involved in the regulation of various cellular processes, including cell growth, metabolism, and stress responses. It is composed of several key components, including the protein known as TOR, which is a key regulator of the pathway, and EPHA6, which is an enzyme that is involved in the regulation of TOR signaling.

EPHA6 is a key enzyme in the TOR pathway because it is involved in the regulation of the activity of TOR, which is a protein that is involved in the regulation of cellular signaling pathways. TOR is a critical regulator of the TOR pathway because it is involved in the regulation of various cellular processes, including cell growth, metabolism, and stress responses.

In addition to its role in the TOR pathway, EPHA6 is also involved in the regulation of other cellular processes. For example, it is involved in the regulation of cell signaling pathways, including the signaling pathway known as the PI3K/Akt pathway. This pathway is involved in the regulation of cellular signaling pathways, including cell growth, metabolism, and stress responses.

EPHA6 is also involved in the regulation of cellular processes related to protein synthesis and degradation. For example, it is involved in the regulation of the translation of mRNAs, which is the process by which proteins are synthesized from the information in DNA. It is also involved in the regulation of protein degradation, which is the process by which proteins that are no longer needed are removed from the cell.

In conclusion, EPHA6 is a protein that is involved in the regulation of various cellular processes. It is a key enzyme in the TOR pathway and is also involved in the regulation of cell signaling pathways, protein synthesis and degradation. These functions make EPHA6 a potential drug target and a biomarker for various diseases.

Protein Name: EPH Receptor A6

Functions: Receptor tyrosine kinase which binds promiscuously GPI-anchored ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling (By similarity)

The "EPHA6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EPHA6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

EPHA7 | EPHA8 | EPHB1 | EPHB2 | EPHB3 | EPHB4 | EPHB6 | Ephrin Receptor | EPHX1 | EPHX2 | EPHX3 | EPHX4 | EPIC1 | EPIST | Epithelial Sodium Channel (ENaC) | EPM2A | EPM2A-DT | EPM2AIP1 | EPN1 | EPN2 | EPN3 | EPO | EPOP | EPOR | Epoxide Hydrolase | EPPIN | EPPK1 | EPRS1 | EPS15 | EPS15L1 | EPS8 | EPS8L1 | EPS8L2 | EPS8L3 | EPSTI1 | EPX | EPYC | EQTN | ER Membrane Protein Complex | ERAL1 | ERAP1 | ERAP2 | ERAS | ERBB2 | ERBB3 | ERBB4 | ERBIN | ERC1 | ERC2 | ERC2-IT1 | ERCC1 | ERCC2 | ERCC3 | ERCC4 | ERCC5 | ERCC6 | ERCC6L | ERCC6L2 | ERCC6L2-AS1 | ERCC8 | EREG | ERF | ERFE | ERG | ERG28 | ERGIC1 | ERGIC2 | ERGIC3 | ERH | ERHP1 | ERI1 | ERI2 | ERI3 | ERICH1 | ERICH2 | ERICH3 | ERICH4 | ERICH5 | ERICH6 | ERICH6-AS1 | ERICH6B | ERLEC1 | ERLIN1 | ERLIN2 | ERLNC1 | ERMAP | ERMARD | ERMN | ERMP1 | ERN1 | ERN2 | ERO1A | ERO1B | ERP27 | ERP29 | ERP44 | ERRFI1 | ERV3-1 | ERVFRD-1 | ERVK-6